AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2016
Dec 23, 2016
3174_iss_2016-12-23_5e172f2a-e519-4c9f-a377-bf326c2ddba1.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktier SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 865,492 |
| Voting rights | 865,492 |
| Transaction | |
| Reason for major shareholding notification Corporate action | |
| Date | 22/12/2016 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 868,103 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 868,103 |
| Percentage | |
| Directly held shares | 4.99 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.99 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.99 % | 868,103 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 4.99 % | 868,103 |
| Chain of controlling companies |
| Voting rights % Voting rights Company | ||
|---|---|---|
| 868,103 | 4.99 | Nordnet Pensionsförsäkring AB |
Group total holdings Voting rights 868,103
Percentage of voting rights 4.99
Notes (other relevant informations according to law)
Nordnet AB genom Nordnet Pensionsförsäkring AB har underskridit tröskelvärdet 5% av antalet utestående röster och aktier i Moberg Pharma AB till följd av nyemission.
Published
23/12/2016 16:29
Contact
Name Gustav Andersson
Phone 0850633236 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13